Scarica l'app Stockscreener
187.50
0.13%
-0.24
Dopo l'orario di chiusura:
187.50
Precedente Chiudi:
$187.74
Aprire:
$185.28
Volume 24 ore:
753.45K
Relative Volume:
1.09
Capitalizzazione di mercato:
$10.63B
Reddito:
$4.08B
Utile/perdita netta:
$431.79M
Rapporto P/E:
19.88
EPS:
9.43
Flusso di cassa netto:
$486.92M
1 W Prestazione:
-15.04%
1M Prestazione:
-5.19%
6M Prestazione:
-15.39%
1 anno Prestazione:
-0.81%
Intervallo 1D:
$183.58
$187.93
Intervallo di 1 settimana:
$183.35
$221.60
Portata 52W:
$176.48
$275.00
Charles River Laboratories International Inc Stock (CRL) Company Profile
Nome
Charles River Laboratories International Inc
Settore
Industria
Telefono
781-222-6000
Indirizzo
251 BALLARDVALE ST, WILMINGTON, MA
Confronta CRL con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
| CRL | 187.50 | 10.63B | 4.08B | 431.79M | 486.92M | 9.43 |
| TMO | 501.29 | 192.46B | 42.37B | 6.14B | 7.78B | 15.26 |
| DHR | 230.06 | 166.23B | 23.74B | 3.89B | 4.98B | 7.93 |
| A | 126.92 | 36.47B | 6.50B | 1.41B | 1.42B | 3.82 |
| IQV | 191.04 | 34.67B | 15.32B | 1.41B | 1.96B | 5.95 |
| IDXX | 419.83 | 34.38B | 3.84B | 866.24M | 792.60M | 9.80 |
Charles River Laboratories International Inc Stock (CRL) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-02-15 | Downgrade | Guggenheim | Buy → Neutral |
| 2023-09-13 | Iniziato | TD Cowen | Market Perform |
| 2023-07-10 | Downgrade | Citigroup | Buy → Neutral |
| 2023-02-23 | Aggiornamento | Guggenheim | Neutral → Buy |
| 2023-01-12 | Downgrade | Jefferies | Buy → Hold |
| 2022-09-30 | Aggiornamento | Jefferies | Hold → Buy |
| 2022-08-25 | Iniziato | Credit Suisse | Outperform |
| 2022-08-04 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2022-05-24 | Iniziato | Guggenheim | Neutral |
| 2022-04-25 | Downgrade | Jefferies | Buy → Hold |
| 2022-04-07 | Iniziato | Stephens | Overweight |
| 2022-02-17 | Reiterato | BofA Securities | Buy |
| 2022-02-17 | Aggiornamento | Citigroup | Neutral → Buy |
| 2022-02-17 | Reiterato | Deutsche Bank | Buy |
| 2022-02-17 | Reiterato | Morgan Stanley | Overweight |
| 2022-02-17 | Reiterato | UBS | Buy |
| 2021-08-05 | Ripresa | Credit Suisse | Neutral |
| 2020-12-16 | Downgrade | Citigroup | Buy → Neutral |
| 2020-09-10 | Aggiornamento | Jefferies | Hold → Buy |
| 2020-07-01 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2020-05-13 | Aggiornamento | UBS | Neutral → Buy |
| 2020-04-21 | Downgrade | Jefferies | Buy → Hold |
| 2020-03-27 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2020-03-02 | Iniziato | Deutsche Bank | Buy |
| 2020-02-18 | Aggiornamento | Wolfe Research | Peer Perform → Outperform |
| 2020-01-10 | Aggiornamento | Goldman | Neutral → Buy |
| 2020-01-08 | Iniziato | Wells Fargo | Overweight |
| 2020-01-07 | Iniziato | Citigroup | Buy |
| 2019-10-18 | Downgrade | BofA/Merrill | Buy → Neutral |
| 2019-06-10 | Iniziato | SVB Leerink | Outperform |
| 2019-04-30 | Ripresa | Evercore ISI | Outperform |
| 2018-12-14 | Iniziato | Deutsche Bank | Buy |
| 2018-10-09 | Iniziato | UBS | Neutral |
| 2018-08-23 | Aggiornamento | Raymond James | Mkt Perform → Outperform |
| 2018-07-17 | Aggiornamento | RBC Capital Mkts | Sector Perform → Outperform |
| 2018-06-15 | Aggiornamento | KeyBanc Capital Mkts | Sector Weight → Overweight |
| 2018-02-14 | Aggiornamento | SunTrust | Hold → Buy |
Mostra tutto
Charles River Laboratories International Inc Borsa (CRL) Ultime notizie
Layoff Tracker: Gilead Sciences Will Lay Off 104 Employees at California HQ - BioSpace
Mawer Investment Management Ltd. Sells 32,693 Shares of Charles River Laboratories International, Inc. (NYSE:CRL) - MarketBeat
Charles River Laboratories International (NYSE:CRL) Rating Lowered to Underperform at CLSA - MarketBeat
Charles River Laboratories International, Inc. (NYSE:CRL) Shares Acquired by Sumitomo Mitsui Trust Group Inc. - MarketBeat
Mizuho Securities USA LLC Buys 92,895 Shares of Charles River Laboratories International, Inc. (NYSE:CRL) - MarketBeat
Charles River Laboratories International, Inc. (NYSE:CRL) Shares Sold by KBC Group NV - MarketBeat
Charles River Labs closes several locations, 1,300+ jobs cut in cost saving initiative - MassLive.com
Pharmaceutical Sterility Testing Market to Drive Revenue to USD 3.79 Billion by 2032 | CAGR 11.58% - GlobeNewswire Inc.
Charles River Laboratories International, Inc. (NYSE:CRL) Holdings Decreased by Victory Capital Management Inc. - MarketBeat
Entropy Technologies LP Reduces Position in Charles River Laboratories International, Inc. (NYSE:CRL) - MarketBeat
Entropy Technologies LP Trims Holdings in Charles River Laboratories International, Inc. (NYSE:CRL) - MarketBeat
Empower Advisory Group LLC Sells 3,497 Shares of Charles River Laboratories International, Inc. (NYSE:CRL) - MarketBeat
Charles River Labs to close Skokie office - Crain's Chicago Business
Charles River Laboratories To Present At UBS Global Healthcare Conference; Webcast At 1:15 PM ET - Nasdaq
Charles River Laboratories International, Inc. (NYSE:CRL) Shares Purchased by WCM Investment Management LLC - MarketBeat
Charles River Laboratories International, Inc. (NYSE:CRL) Position Lowered by Amalgamated Bank - MarketBeat
Genotoxicity Tests Market Trends Detailed Research and Projected Growth through 2032 - WICZ
Charles River Laboratories International (NYSE:CRL) Stock Price Expected to Rise, TD Cowen Analyst Says - MarketBeat
Charles River (CRL) International Revenue in Focus: Trends and Expectations - Yahoo Finance
Charles River Labs to Present Strategic Updates at UBS and Jefferies Healthcare Events | CRL Stock News - StockTitan
Shareholders Can't Ignore US$5.2m Of Sales By Charles River Laboratories International Insiders - Simply Wall St
William Blair Brokers Decrease Earnings Estimates for CRL - MarketBeat
Jensen Investment Management Inc. Decreases Stock Position in Charles River Laboratories International, Inc. (NYSE:CRL) - MarketBeat
Wellington Management Group LLP's Strategic Acquisition in Charles River Laboratories - GuruFocus.com
Charles River Laboratories International, Inc. (NYSE:CRL) Q3 2024 Earnings Call Transcript - Insider Monkey
Charles River Laboratories International Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags - Yahoo Finance
Earnings call: Charles River Laboratories reports Q3 2024 results - Investing.com
Evercore ISI Issues Positive Forecast for Charles River Laboratories International (NYSE:CRL) Stock Price - MarketBeat
CLSA Upgrades Charles River Laboratories International (NYSE:CRL) to Hold - MarketBeat
Charles River Labs Raises Profit Outlook After Strong Quarter - Finimize
Five things you need to know, and a lesson from presidential history - The Business Journals
Animal Model Market Generated Opportunities, Future Scope - openPR
Van ECK Associates Corp Cuts Stock Position in Charles River Laboratories International, Inc. (NYSE:CRL) - MarketBeat
Charles River Laboratories International Inc (CRL) Q3 2024 Earni - GuruFocus.com
Decoding Charles River Laboratories International Inc (CRL): A S - GuruFocus.com
Charles River Earnings: Headwinds From Reduced Client Spending; Positive Long-Term Outlook - Morningstar
Charles River Laboratories International Inc (CRL) Q3 2024 Earnings Call Highlights: Navigating ... - Yahoo Finance UK
Charles River Laboratories Announces Third-Quarter 2024 Results - citybiz
Decoding Charles River Laboratories International Inc (CRL): A Strategic SWOT Insight - Yahoo Finance
Charles River Laboratories Reports 2024 Q3 Financial Results - TipRanks
Charles River Laboratories Q3 2024 Earnings Preview - MSN
Charles River: Q3 Earnings Snapshot - The Washington Post
Charles River Laboratories International Inc (CRL) Stock Price U - GuruFocus.com
Massachusetts-based Charles River Labs cuts 1,300 workers, will close over a dozen sites - NBC Boston
Charles River Labs cuts 1,300 workers; will close more than a dozen sites - The Business Journals
Charles River's Q3 Earnings, Revenues Beat Estimates, Margins Fall - Yahoo Finance
Why Is Charles River Laboratories Stock Trading Higher On Wednesday?Charles River (NYSE:CRL) - Benzinga
Charles River (CRL) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates - Yahoo Finance
Charles River Laboratories International, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 28, 2024 - Marketscreener.com
Charles River Laboratories International (NYSE:CRL) Releases FY 2024 Earnings Guidance - MarketBeat
Charles River Laboratories International Q3 24 Earnings Conference Call At 9:30 AM ET - Nasdaq
Charles River Laboratories International Inc Azioni (CRL) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
5.04%
3.19%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):